2024-12-20 18:53:54

Novo Nordisk fell more than 19 percent in premarket trading after the company reported weaker-than-expected data for its weight-loss drug Cagrisema, while Eli Lilly (LLY.N) rose nearly 6 percent in premarket trading.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download